Risk-based and diagnostics-linked personalized medicine for cancer

ISSN： 1741-0541

Source： Personalized Medicine, Vol.4, Iss.1, 2007-02, pp. : 33-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. : 252-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development and validation of risk models and molecular diagnostics to permit personalized management of cancer

CANCER, Vol. 120, Iss. 1, 2014-01 ,pp. : 11-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Breast cancer screening in an era of personalized regimens: A conceptual model and National Cancer Institute initiative for risk‐based and preference‐based approaches at a population level

CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. : 2955-2964

John Wiley & Sons Inc

Access to resources Recommend Favorite

Valuing personalized medicine: willingness to pay for genetic testing for colorectal cancer risk

By Van Bebber Stephanie L Liang Su-Ying Phillips Kathryn A Marshall Deborah Walsh Judith Kulin Nathalie

Personalized Medicine, Vol. 4, Iss. 3, 2007-08 ,pp. : 341-350

Future Medicine

Access to resources Recommend Favorite

Personalized Cancer Medicine

Oncology Research and Treatment, Vol. 35, Iss. 1, 2012-01 ,pp. : 2-2

Karger

Access to resources Recommend Favorite